S17 / Operate

PM · clinical trials.

Project management for full clinical Phase I-IV. Sponsor-side or CRO-side. Quality-first orientation under ICH E6(R3).

5 min read

You'll leave with: What quality-first clinical PM under E6(R3) looks like — and why it differs from scope/timeline-first PM.

Note: Building RBQM case study for full credibility on Phase II/III.

/ Who this is for

The fit.

Sponsors needing PM oversight under quality-first framing. Small biotechs without internal PM team.

/ The work itself

What this delivers.

Quality-first PM. RBQM-native per ICH E6(R3). Risk-based monitoring, critical-to-quality factors integrated.

/ Why this matters

Where the edge is.

Quality-first PM (RBQM-native per E6(R3)) — less common than scope/timeline-first PM. Most PMs treat quality as a constraint; this approach treats it as the operating principle.

/ How engagement runs

The shape of the work.

Every engagement is scoped per situation. The shape — focused diagnostic, structured implementation, ongoing partnership — emerges from the discovery conversation rather than a fixed package. Some engagements are short and intense; some are months-long structural builds; some are recurring quality oversight. We talk first, then scope.

Discovery.

Confirm trial scope, phase, therapeutic area.

Scoping.

Per-study or per-phase proposal.

Manage.

RBQM PM throughout trial.

Closeout.

CSR-ready package, lessons learned.

What to do next.

If this is the work in front of you, the next step is a conversation. I read every message and respond personally. No contact forms. No sales sequence. Just a discovery conversation to understand whether the fit is real, and what the shape of the work would be.

Cadence promise: I publish weekly on regulated AI governance. If a week is missed, the journal entry explaining why goes up in real-time.

DM on LinkedIn → Email → Browse all collaboration shapes →